Fred J. Dotzler
Fondatore presso De Novo Ventures LLC
Profilo
Fred J.
Dotzler founded De Novo Ventures LLC in 2000, where he is working as Managing Director from 2000 and Medicus Venture Partners in 1989, where he worked as Managing General Partner from 2009 to 2011.
Mr. Dotzler also currently works at Astute Medical, Inc., as Director, GenoRx, Inc., as Director, and Cartilix, Inc., as Director.
Mr. Dotzler also formerly worked at HemaQuest Pharmaceuticals, Inc., as Chairman, Bayhill Therapeutics, Inc., as Director from 2004 to 2013, SenoRx, Inc., as Director from 1998 to 2002, SenoRx, Inc., as Director from 2003 to 2010, iScience Interventional Corp., as Director, VitreoRetinal Technologies, Inc., as Director, Talima Therapeutics, Inc., as Director, Crosspoint Venture Partners, as General Partner, Merrimack Pharmaceuticals, Inc., as Principal, International Business Machines Corp., as Principal, G.D.
Searle & Co., Inc., as Principal, and EMD Millipore Corp., as Principal.
Mr. Dotzler received his graduate degree from Université Catholique de Louvain, undergraduate degree from Iowa State University, and Masters Business Admin degree from The University of Chicago.
Posizioni attive di Fred J. Dotzler
| Società | Posizione | Inizio |
|---|---|---|
De Novo Ventures LLC
 De Novo Ventures LLC Investment ManagersFinance De Novo Ventures LLC (De Novo ventures) is a venture capital firm founded in 2000 by Frederick Dotzler, Richard Ferrari and David Mauney. The firm is headquartered in Menlo Park, California. | Fondatore | 01/01/2000 |
Cartilix, Inc.
 Cartilix, Inc. Medical SpecialtiesHealth Technology Cartilix, Inc. develops surgical devices and associated biomaterials to treat focal cartilage defects in joints. Its technology is used in wound sealing solutions, spinal disc regeneration, and other biological interfaces. The company was founded by Frank Huerta, Norman A. Marcus, and Jennifer Elisseeff in July 2004 and is headquartered in Foster City, CA | Direttore/Membro del Consiglio | - |
GenoRx, Inc.
 GenoRx, Inc. Medical/Nursing ServicesHealth Services GenoRx, Inc. develops DNA on a chip technology. It develops bioelectronic detection tools that will provide the creation of targeted therapeutics, improved diagnostics and healthier agricultural products. It also provides Biosensing chips to rapidly characterize RNA and DNA for disease diagnosis and scientific research. The company was founded in 2000 and is headquartered in Hayward, CA. | Direttore/Membro del Consiglio | - |
Astute Medical, Inc.
 Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Astute Medical, Inc. discovers and develops biomarkers for acute conditions and diseases. It develops protein biomarker-based diagnostics technology for high-risk medical conditions such as cerebrovascular injury, kidney injury, sepsis, abdominal pain, and acute coronary syndromes. The firm’s products include NephroCheck test and Astute140 meter kits. The company was founded by Christopher Richard Hibberd and Paul H. McPherson in 2007 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Fred J. Dotzler
| Società | Posizione | Fine |
|---|---|---|
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Direttore/Membro del Consiglio | 26/12/2013 |
SenoRx, Inc.
 SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Direttore/Membro del Consiglio | 06/07/2010 |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Direttore/Membro del Consiglio | 01/03/2002 |
| IBM | Corporate Officer/Principal | - |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
Formazione di Fred J. Dotzler
| Iowa State University | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
| Université Catholique de Louvain | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IBM | Technology Services |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 14 |
|---|---|
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Crosspoint Venture Partners
 Crosspoint Venture Partners Investment ManagersFinance Crosspoint Venture Partners (Crosspoint Venture Partners) is a venture capital firm founded in 1970 by John B. Mumford. The firm is headquartered in Redwood City, California. | Finance |
GenoRx, Inc.
GenoRx, Inc. Medical/Nursing ServicesHealth Services GenoRx, Inc. develops DNA on a chip technology. It develops bioelectronic detection tools that will provide the creation of targeted therapeutics, improved diagnostics and healthier agricultural products. It also provides Biosensing chips to rapidly characterize RNA and DNA for disease diagnosis and scientific research. The company was founded in 2000 and is headquartered in Hayward, CA. | Health Services |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Cartilix, Inc.
Cartilix, Inc. Medical SpecialtiesHealth Technology Cartilix, Inc. develops surgical devices and associated biomaterials to treat focal cartilage defects in joints. Its technology is used in wound sealing solutions, spinal disc regeneration, and other biological interfaces. The company was founded by Frank Huerta, Norman A. Marcus, and Jennifer Elisseeff in July 2004 and is headquartered in Foster City, CA | Health Technology |
Talima Therapeutics, Inc.
 Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Health Technology |
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
VitreoRetinal Technologies, Inc.
 VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Astute Medical, Inc.
Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Astute Medical, Inc. discovers and develops biomarkers for acute conditions and diseases. It develops protein biomarker-based diagnostics technology for high-risk medical conditions such as cerebrovascular injury, kidney injury, sepsis, abdominal pain, and acute coronary syndromes. The firm’s products include NephroCheck test and Astute140 meter kits. The company was founded by Christopher Richard Hibberd and Paul H. McPherson in 2007 and is headquartered in San Diego, CA. | Electronic Technology |
Medicus Venture Partners
 Medicus Venture Partners Investment ManagersFinance Medicus Venture Partners (MVP) is a venture capital firm located in Saratoga, California. | Finance |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
De Novo Ventures LLC
De Novo Ventures LLC Investment ManagersFinance De Novo Ventures LLC (De Novo ventures) is a venture capital firm founded in 2000 by Frederick Dotzler, Richard Ferrari and David Mauney. The firm is headquartered in Menlo Park, California. | Finance |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Health Technology |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Fred J. Dotzler
